114 related articles for article (PubMed ID: 10959906)
1. Continuous octreotide infusion for the treatment of secretory diarrhea caused by acute intestinal graft-versus-host disease in a child.
Beckman RA; Siden R; Yanik GA; Levine JE
J Pediatr Hematol Oncol; 2000; 22(4):344-50. PubMed ID: 10959906
[TBL] [Abstract][Full Text] [Related]
2. Use of octreotide in the symptomatic management of diarrhea induced by graft-versus-host disease in patients with hematologic malignancies.
Ippoliti C; Champlin R; Bugazia N; Przepiorka D; Neumann J; Giralt S; Khouri I; Gajewski J
J Clin Oncol; 1997 Nov; 15(11):3350-4. PubMed ID: 9363865
[TBL] [Abstract][Full Text] [Related]
3. Use of a somatostatin analogue, octreotide acetate, in the management of acute gastrointestinal graft-versus-host disease.
Ely P; Dunitz J; Rogosheske J; Weisdorf D
Am J Med; 1991 Jun; 90(6):707-10. PubMed ID: 2042686
[TBL] [Abstract][Full Text] [Related]
4. Octreotide in the management of diarrhea induced by graft versus host disease.
Ippoliti C; Neumann J
Oncol Nurs Forum; 1998 Jun; 25(5):873-8. PubMed ID: 9644703
[TBL] [Abstract][Full Text] [Related]
5. The somatostatin analog octreotide in the management of the secretory diarrhea of the acute intestinal graft-versus-host disease in a patient after bone marrow transplantation.
Bianco JA; Higano C; Singer J; Appelbaum FR; McDonald GB
Transplantation; 1990 Jun; 49(6):1194-5. PubMed ID: 2360261
[No Abstract] [Full Text] [Related]
6. Efficacy of octreotide in controlling refractory diarrhea following bone marrow transplantation.
Morton AJ; Durrant ST
Clin Transplant; 1995 Jun; 9(3 Pt 1):205-8. PubMed ID: 7549062
[TBL] [Abstract][Full Text] [Related]
7. The efficacy of octreotide in the therapy of acute radiation-induced diarrhea: a randomized controlled study.
Yavuz MN; Yavuz AA; Aydin F; Can G; Kavgaci H
Int J Radiat Oncol Biol Phys; 2002 Sep; 54(1):195-202. PubMed ID: 12182992
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial of loperamide versus dose escalation of octreotide acetate for chemotherapy-induced diarrhea in bone marrow transplant and leukemia patients.
Geller RB; Gilmore CE; Dix SP; Lin LS; Topping DL; Davidson TG; Holland HK; Wingard JR
Am J Hematol; 1995 Nov; 50(3):167-72. PubMed ID: 7485077
[TBL] [Abstract][Full Text] [Related]
9. Octreotide acetate is efficacious and safe in children for treating diarrhea due to chemotherapy but not acute graft versus host disease.
Pai V; Porter K; Ranalli M
Pediatr Blood Cancer; 2011 Jan; 56(1):45-9. PubMed ID: 21108438
[TBL] [Abstract][Full Text] [Related]
10. A comparative study of racecadotril and single dose octreotide as an anti-secretory agent in acute infective diarrhoea.
Mehta S; Khandelwal PD; Jain VK; Sihag M
J Assoc Physicians India; 2012 Nov; 60():12-5. PubMed ID: 23767196
[TBL] [Abstract][Full Text] [Related]
11. Antidiarrheal agents for the management of treatment-related diarrhea in cancer patients.
Ippoliti C
Am J Health Syst Pharm; 1998 Aug; 55(15):1573-80. PubMed ID: 9706182
[TBL] [Abstract][Full Text] [Related]
12. Effect of octreotide on small intestinal motility in HIV-infected patients with chronic refractory diarrhea.
Neild PJ; Evans DF; Castillo FD; Newson R; Yasaki ET; Wingate DL; Gazzard BG
Dig Dis Sci; 2001 Dec; 46(12):2636-42. PubMed ID: 11768253
[TBL] [Abstract][Full Text] [Related]
13. Octreotide acetate in refractory bone marrow transplant-associated diarrhea.
Crouch MA; Restino MS; Cruz JM; Perry JJ; Hurd DD
Ann Pharmacother; 1996 Apr; 30(4):331-6. PubMed ID: 8729883
[TBL] [Abstract][Full Text] [Related]
14. Bowel rest, intravenous hydration, and continuous high-dose infusion of octreotide acetate for the treatment of chemotherapy-induced diarrhea in patients with colorectal carcinoma.
Petrelli NJ; Rodriguez-Bigas M; Rustum Y; Herrera L; Creaven P
Cancer; 1993 Sep; 72(5):1543-6. PubMed ID: 8348489
[TBL] [Abstract][Full Text] [Related]
15. [CD25 monoclonal antibody for GVHD prophylaxis in non-T-cell depleted haploidentical bone marrow transplantation for treatment of childhood leukemia].
Chen HR; Ji SQ; Yan HM; Wang HX; Liu J; Xue M; Zhu L
Zhonghua Er Ke Za Zhi; 2004 Apr; 42(4):294-8. PubMed ID: 15157394
[TBL] [Abstract][Full Text] [Related]
16. Octreotide in the treatment of severe chemotherapy-induced diarrhea.
Zidan J; Haim N; Beny A; Stein M; Gez E; Kuten A
Ann Oncol; 2001 Feb; 12(2):227-9. PubMed ID: 11300329
[TBL] [Abstract][Full Text] [Related]
17. Successful treatment of steroid-resistant severe acute GVHD with 24-h continuous infusion of FK506.
Ohashi Y; Minegishi M; Fujie H; Tsuchiya S; Konno T
Bone Marrow Transplant; 1997 Mar; 19(6):625-7. PubMed ID: 9085743
[TBL] [Abstract][Full Text] [Related]
18. Octreotide for symptomatic treatment of diarrhea due to cytomegalovirus colitis.
Bartels MC; Mergenhagen KA
Ann Pharmacother; 2011 Jan; 45(1):e4. PubMed ID: 21189368
[TBL] [Abstract][Full Text] [Related]
19. Single-dose daily infusion of cyclosporine for prevention of Graft-versus-host disease after allogeneic bone marrow transplantation from HLA allele-matched, unrelated donors.
Nawa Y; Hara M; Tanimoto K; Nakase K; Kozuka T; Maeda Y
Int J Hematol; 2006 Feb; 83(2):159-63. PubMed ID: 16513536
[TBL] [Abstract][Full Text] [Related]
20. Acute intestinal graft-versus-host disease in a syngeneic bone marrow transplant recipient.
Spaner D; Lowsky R; Fyles G; Lipton JH; Banerjee D; Ng CM; Wade JA; Messner HA
Transplantation; 1998 Nov; 66(9):1251-3. PubMed ID: 9825825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
